{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["diabetes", "herbal", "medicine", "retinopathy", "traditional"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28054988", "DateCompleted": {"Year": "2017", "Month": "04", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "01", "Day": "04"}], "Language": ["eng"], "ELocationID": ["76", "10.3390/molecules22010076"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Jan", "Day": "04"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy.", "Abstract": {"AbstractText": ["Diabetes mellitus is one of the most frequent endocrine disorders, affecting populations worldwide. Diabetic retinopathy (DR) is the most frequent microvascular complication of diabetes in patients aged 20 and over. Major complications of DR include intraocular neovascularization, inter-retinal edema, hemorrhage, exudates and microaneurysms. Therefore, timely medical attention and prevention are required. At present, laser-assisted therapy and other operational procedures are the most common treatment for DR. However, these treatments can cause retinal damage and scarring. Also, use of the majority of traditional medicines is not supported by clinical evidence. However, due to accumulating scientific evidence, traditional natural medications may assist in delaying or preventing the progression of DR. This review focuses on evidence for the role of traditional natural medicines and their mechanisms of action and pharmacological test results in relation to the progression of DR."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Konkuk University, Chungju 380-701, Korea. sandeepbcp@gmail.com."}], "LastName": "Vasant More", "ForeName": "Sandeep", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Konkuk University, Chungju 380-701, Korea. kis5497@kku.ac.kr."}], "LastName": "Kim", "ForeName": "In-Su", "Initials": "IS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Konkuk University, Chungju 380-701, Korea. choidk@kku.ac.kr."}], "LastName": "Choi", "ForeName": "Dong-Kug", "Initials": "DK"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Materia Medica"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Diabetic Retinopathy"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Materia Medica"}, {"QualifierName": ["methods"], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["pathology", "prevention & control"], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": ["chemistry", "classification"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Retina"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011;94:311\u2013321. doi: 10.1016/j.diabres.2011.10.029.", "ArticleIdList": ["10.1016/j.diabres.2011.10.029", "22079683"]}, {"Citation": "Chistiakov D.A. Diabetic retinopathy: Pathogenic mechanisms and current treatments. Diabetes Metab. Syndr. Clin. Res. Rev. 2011;5:165\u2013172. doi: 10.1016/j.dsx.2012.02.025.", "ArticleIdList": ["10.1016/j.dsx.2012.02.025", "22813573"]}, {"Citation": "Scanlon P.H. Diabetic retinopathy. Medicine. 2010;38:656\u2013660. doi: 10.1016/j.mpmed.2010.08.010.", "ArticleIdList": ["10.1016/j.mpmed.2010.08.010"]}, {"Citation": "Shin E.S., Sorenson C.M., Sheibani N. Diabetes and retinal vascular dysfunction. J. Ophthalmic Vis. Res. 2014;9:362.", "ArticleIdList": ["PMC4307665", "25667739"]}, {"Citation": "Resnikoff S., Pascolini D., Etya\u2019ale D., Kocur I., Pararajasegaram R., Pokharel G.P., Mariotti S.P. Global data on visual impairment in the year 2002. Bull. World Health Organ. 2004;82:844\u2013851.", "ArticleIdList": ["PMC2623053", "15640920"]}, {"Citation": "Control D., Group C.T.R. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993;329:977\u2013986.", "ArticleIdList": ["8366922"]}, {"Citation": "Stratton I., Kohner E., Aldington S., Turner R., Holman R., Manley S., Matthews D. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156\u2013163. doi: 10.1007/s001250051594.", "ArticleIdList": ["10.1007/s001250051594", "11270671"]}, {"Citation": "Klein R., Klein B.E., Moss S.E., Cruickshanks K.J. The Wisconsin epidemiologic study of diabetic retinopathy: XIV. Ten-year incidence and progression of diabetic retinopathy. Arch. Ophthalmol. 1994;112:1217\u20131228. doi: 10.1001/archopht.1994.01090210105023.", "ArticleIdList": ["10.1001/archopht.1994.01090210105023", "7619101"]}, {"Citation": "Klein R., Knudtson M.D., Lee K.E., Gangnon R., Klein B.E. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII: The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115:1859\u20131868. doi: 10.1016/j.ophtha.2008.08.023.", "ArticleIdList": ["10.1016/j.ophtha.2008.08.023", "PMC2761813", "19068374"]}, {"Citation": "Aiello L.P., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris F.L., 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 1998;21:143\u2013156. doi: 10.2337/diacare.21.1.143.", "ArticleIdList": ["10.2337/diacare.21.1.143", "9538986"]}, {"Citation": "Patel S., Chen H., Tinkham N.H., Zhang K. Genetic susceptibility of diabetic retinopathy. Curr. Diabetes Rep. 2008;8:257\u2013262. doi: 10.1007/s11892-008-0046-6.", "ArticleIdList": ["10.1007/s11892-008-0046-6", "18631436"]}, {"Citation": "Warpeha K., Chakravarthy U. Molecular genetics of microvascular disease in diabetic retinopathy. Eye. 2003;17:305\u2013311. doi: 10.1038/sj.eye.6700348.", "ArticleIdList": ["10.1038/sj.eye.6700348", "12724690"]}, {"Citation": "Durham J.T., Herman I.M. Microvascular modifications in diabetic retinopathy. Curr. Diabetes Rep. 2011;11:253\u2013264. doi: 10.1007/s11892-011-0204-0.", "ArticleIdList": ["10.1007/s11892-011-0204-0", "21611764"]}, {"Citation": "Hudson C. The clinical features and classification of diabetic retinopathy. Ophthalmic Physiol. Opt. 1996;16:S43\u2013S48. doi: 10.1016/0275-5408(96)00026-9.", "ArticleIdList": ["10.1016/0275-5408(96)00026-9", "9398920"]}, {"Citation": "Ola M.S., Nawaz M.I., Siddiquei M.M., Al-Amro S., El-Asrar A.M.A. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J. Diabetes Complicat. 2012;26:56\u201364. doi: 10.1016/j.jdiacomp.2011.11.004.", "ArticleIdList": ["10.1016/j.jdiacomp.2011.11.004", "22226482"]}, {"Citation": "Wilkinson C., Ferris F.L., Klein R.E., Lee P.P., Agardh C.D., Davis M., Dills D., Kampik A., Pararajasegaram R., Verdaguer J.T. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677\u20131682. doi: 10.1016/S0161-6420(03)00475-5.", "ArticleIdList": ["10.1016/S0161-6420(03)00475-5", "13129861"]}, {"Citation": "Patel A., Group A.C. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet. 2007;370:829\u2013840. doi: 10.1016/S0140-6736(07)61303-8.", "ArticleIdList": ["10.1016/S0140-6736(07)61303-8", "17765963"]}, {"Citation": "Lang G. Laser treatment of diabetic retinopathy. Dev. Ophthalmol. 2007;39:48\u201368.", "ArticleIdList": ["17245078"]}, {"Citation": "Lewis H. The role of vitrectomy in the treatment of diabetic macular edema. Am. J. Ophthalmol. 2001;131:123\u2013125. doi: 10.1016/S0002-9394(00)00660-7.", "ArticleIdList": ["10.1016/S0002-9394(00)00660-7", "11162987"]}, {"Citation": "Li D.-D., Chen J.-H., Chen Q., Li G.-W., Chen J., Yue J.-M., Chen M.-L., Wang X.-P., Shen J.-H., Shen X. Swietenia mahagony extract shows agonistic activity to PPAR gamma and gives ameliorative effects on diabetic db/db mice. Acta Pharmacol. Sin. 2005;26:220\u2013222. doi: 10.1111/j.1745-7254.2005.00527.x.", "ArticleIdList": ["10.1111/j.1745-7254.2005.00527.x", "15663902"]}, {"Citation": "Al-Rowais N.A. Herbal medicine in the treatment of diabetes mellitus. Saudi Med. J. 2002;23:1327\u20131331.", "ArticleIdList": ["12506289"]}, {"Citation": "Bailey C.J., Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care. 1989;12:553\u2013564. doi: 10.2337/diacare.12.8.553.", "ArticleIdList": ["10.2337/diacare.12.8.553", "2673695"]}, {"Citation": "Dey L., Attele A. Alternative therapies for type 2 Diabetes. Altern. Med. Rev. 2002;7:45\u201358.", "ArticleIdList": ["11896745"]}, {"Citation": "Head K. Natural therapies for ocular disorders, part one: Diseases of the retina. Altern. Med. Rev. J. Clin. Ther. 1999;4:342\u2013359.", "ArticleIdList": ["10559549"]}, {"Citation": "Ceylan-Isik A.F., Fliethman R.M., Wold L.E., Ren J. Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus. Curr. Diabetes Rev. 2008;4:320\u2013328. doi: 10.2174/157339908786241142.", "ArticleIdList": ["10.2174/157339908786241142", "18991600"]}, {"Citation": "World Health Organization  WHO Traditional Medicine Strategy 2014\u20132023.  [(accessed on 15 May 2016)].  Available online:  http://apps.who.int/iris/handle/10665/92455."}, {"Citation": "World Health Organization  Legal Status of Traditional Medicine and Complementary/Alternative Medicine: A Worldwide Review.  [(accessed on 15 May 2016)].  Available online:  http://apps.who.int/medicinedocs/en/d/Jh2943e/"}, {"Citation": "Patwardhan B., Mashelkar R.A. Traditional medicine-inspired approaches to drug discovery: Can Ayurveda show the way forward? Drug Discov. Today. 2009;14:804\u2013811. doi: 10.1016/j.drudis.2009.05.009.", "ArticleIdList": ["10.1016/j.drudis.2009.05.009", "19477288"]}, {"Citation": "Hughes B. 2008 FDA drug approvals. Nat. Rev. Drug Discov. 2009;8:93\u201396. doi: 10.1038/nrd2813.", "ArticleIdList": ["10.1038/nrd2813", "19180096"]}, {"Citation": "Kong D.-X., Li X.-J., Zhang H.-Y. Where is the hope for drug discovery? Let history tell the future. Drug Discov. Today. 2009;14:115\u2013119. doi: 10.1016/j.drudis.2008.07.002.", "ArticleIdList": ["10.1016/j.drudis.2008.07.002", "18687410"]}, {"Citation": "Wang Z., Wang J., Chan P. Treating type 2 diabetes mellitus with traditional Chinese and Indian medicinal herbs. Evid.-Based Complement. Altern. Med. 2013;2013:70\u201375. doi: 10.1155/2013/343594.", "ArticleIdList": ["10.1155/2013/343594", "PMC3662109", "23737828"]}, {"Citation": "Kim J., Kim C.-S., Lee Y.M., Sohn E., Jo K., Kim J.S. Litsea japonica extract inhibits neuronal apoptosis and the accumulation of advanced glycation end products in the diabetic mouse retina. Mol. Med. Rep. 2015;12:1075\u20131081.", "ArticleIdList": ["PMC4438968", "25815519"]}, {"Citation": "Shin J.Y., Sohn J., Park K.H. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model. J. Korean Med. Sci. 2013;28:608\u2013613. doi: 10.3346/jkms.2013.28.4.608.", "ArticleIdList": ["10.3346/jkms.2013.28.4.608", "PMC3617316", "23579598"]}, {"Citation": "Kumar B., Gupta S.K., Nag T.C., Srivastava S., Saxena R., Jha K.A., Srinivasan B.P. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats. Exp. Eye Res. 2014;125:193\u2013202. doi: 10.1016/j.exer.2014.06.009.", "ArticleIdList": ["10.1016/j.exer.2014.06.009", "24952278"]}, {"Citation": "Yu Z., Lu B., Sheng Y., Zhou L., Ji L., Wang Z. Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation. Biochim. Biophys. Acta (BBA) Gen. Subj. 2015;1850:824\u2013831. doi: 10.1016/j.bbagen.2015.01.014.", "ArticleIdList": ["10.1016/j.bbagen.2015.01.014", "25641276"]}, {"Citation": "Ding Y., Yuan S., Liu X., Mao P., Zhao C., Huang Q., Zhang R., Fang Y., Song Q., Yuan D. Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy. PLoS ONE. 2014;9:e112207. doi: 10.1371/journal.pone.0112207.", "ArticleIdList": ["10.1371/journal.pone.0112207", "PMC4239035", "25411784"]}, {"Citation": "Kim J.H., Lee Y.M., Ahn E.M., Kim K.W., Yu Y.S. Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation. Mol. Vis. 2009;15:1868\u20131875.", "ArticleIdList": ["PMC2743803", "19756180"]}, {"Citation": "Gong C.-Y., Yu Z.-Y., Lu B., Yang L., Sheng Y.-C., Fan Y.-M., Ji L.-L., Wang Z.-T. Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism. Vasc. Pharmacol. 2014;62:134\u2013142. doi: 10.1016/j.vph.2014.04.007.", "ArticleIdList": ["10.1016/j.vph.2014.04.007", "24846859"]}, {"Citation": "Lee S.-Y., Min B.-S., Kim J.-H., Lee J.-K., Kim T.-J., Kim C.-S., Kim Y.-H., Lee H.-K. Flavonoids from the leaves of Litsea japonica and their anti-complement activity. Phytother. Res. 2005;19:273\u2013276. doi: 10.1002/ptr.1453.", "ArticleIdList": ["10.1002/ptr.1453", "16041765"]}, {"Citation": "Min B.S., Lee S.Y., Kim J.H., Kwon O.K., Park B.Y., An R.B., Lee J.K., Moon H.I., Kim T.J., Kim Y.H. Lactones from the Leaves of Litsea j aponica and Their Anti-complement Activity. J. Nat. Prod. 2003;66:1388\u20131390. doi: 10.1021/np030227i.", "ArticleIdList": ["10.1021/np030227i", "14575444"]}, {"Citation": "Kim J., Kim C.-S., Lee I.S., Lee Y.M., Sohn E., Jo K., Kim J.H., Kim J.S. Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice. Endocrine. 2014;46:462\u2013469. doi: 10.1007/s12020-013-0085-x.", "ArticleIdList": ["10.1007/s12020-013-0085-x", "24287793"]}, {"Citation": "Howes M.-J.R., Perry N.S., Houghton P.J. Plants with traditional uses and activities, relevant to the management of Alzheimer\u2019s disease and other cognitive disorders. Phytother. Res. 2003;17 doi: 10.1002/ptr.1280.", "ArticleIdList": ["10.1002/ptr.1280", "12557240"]}, {"Citation": "Bhatt K., Flora S. Oral co-administration of \u03b1-lipoic acid, quercetin and captopril prevents gallium arsenide toxicity in rats. Environ. Toxicol. Pharmacol. 2009;28:140\u2013146. doi: 10.1016/j.etap.2009.03.012.", "ArticleIdList": ["10.1016/j.etap.2009.03.012", "21783994"]}, {"Citation": "Bronner C., Landry Y. Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions. 1985;16:147\u2013151. doi: 10.1007/BF01983124.", "ArticleIdList": ["10.1007/BF01983124", "2409764"]}, {"Citation": "Fiorani M., de Sanctis R., Menghinello P., Cucchiarini L., Cellini B., Dach\u00e0 M. Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells. Free Radic. Res. 2009;34:639\u2013648. doi: 10.1080/10715760100300531.", "ArticleIdList": ["10.1080/10715760100300531", "11697039"]}, {"Citation": "Chen Y., Li X.-X., Xing N.-Z., Cao X.-G. Quercetin inhibits choroidal and retinal angiogenesis in vitro. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 2007;246:373\u2013378. doi: 10.1007/s00417-007-0728-9.", "ArticleIdList": ["10.1007/s00417-007-0728-9", "18087712"]}, {"Citation": "Cao X., Liu M., Tuo J., Shen D., Chan C.-C. The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp. Eye Res. 2010;91:15\u201325. doi: 10.1016/j.exer.2010.03.016.", "ArticleIdList": ["10.1016/j.exer.2010.03.016", "PMC2879439", "20361964"]}, {"Citation": "Kumar B., Gupta S.K., Nag T.C., Srivastava S., Saxena R. Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats. Ophthalmic Res. 2012;47:103\u2013108. doi: 10.1159/000330051.", "ArticleIdList": ["10.1159/000330051", "21997135"]}, {"Citation": "Kumar Gupta S., Kumar B., Srinivasan B., Nag T.C., Srivastava S., Saxena R., Aggarwal A. Retinoprotective effects of Moringa oleifera via antioxidant, anti-inflammatory, and anti-angiogenic mechanisms in streptozotocin-induced diabetic rats. J. Ocul. Pharmacol. Ther. 2013;29:419\u2013426. doi: 10.1089/jop.2012.0089.", "ArticleIdList": ["10.1089/jop.2012.0089", "23215831"]}, {"Citation": "Kim J., Kim K.M., Kim C.-S., Sohn E., Lee Y.M., Jo K., Kim J.S. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radic. Biol. Med. 2012;53:357\u2013365. doi: 10.1016/j.freeradbiomed.2012.04.030.", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.04.030", "22609359"]}, {"Citation": "Teng Y., Cui H., Yang M., Song H., Zhang Q., Su Y., Zheng J. Protective effect of puerarin on diabetic retinopathy in rats. Mol. Biol. Rep. 2009;36:1129\u20131133. doi: 10.1007/s11033-008-9288-2.", "ArticleIdList": ["10.1007/s11033-008-9288-2", "18587665"]}, {"Citation": "Hsu F.-L., Liu I.-M., Kuo D.-H., Chen W.-C., Su H.-C., Cheng J.-T. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J. Nat. Prod. 2003;66:788\u2013792. doi: 10.1021/np0203887.", "ArticleIdList": ["10.1021/np0203887", "12828463"]}, {"Citation": "Liang X., Xiao S., Lu G., Liang Y., Bi X. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur. J. Pharmacol. 2006;529:1\u20137. doi: 10.1016/j.ejphar.2005.10.024.", "ArticleIdList": ["10.1016/j.ejphar.2005.10.024", "16321378"]}, {"Citation": "Kim J.M., Lee Y.M., Lee G.Y., Jang D.S., Bae K.H., Kim J.S. Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs) Arch. Pharm. Res. 2006;29:821\u2013825. doi: 10.1007/BF02973900.", "ArticleIdList": ["10.1007/BF02973900", "17121174"]}, {"Citation": "Liu W., Guo W., Guo L., Gu Y., Cai P., Xie N., Yang X., Shu Y., Wu X., Sun Y. Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response. Int. Immunopharmacol. 2014;20:337\u2013345. doi: 10.1016/j.intimp.2014.03.015.", "ArticleIdList": ["10.1016/j.intimp.2014.03.015", "24704625"]}, {"Citation": "Hao L.-N., Wang M., Ma J.-L., Yang T. Puerarin decreases apoptosis of retinal pigment epithelial cells in diabetic rats by reducing peroxynitrite level and iNOS expression. Sheng Li Xue Bao. 2012;64:199\u2013206.", "ArticleIdList": ["22513471"]}, {"Citation": "Shang X., Pan H., Li M., Miao X., Ding H. Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J. Ethnopharmacol. 2011;138:1\u201321. doi: 10.1016/j.jep.2011.08.016.", "ArticleIdList": ["10.1016/j.jep.2011.08.016", "PMC7127058", "21864666"]}, {"Citation": "Lin L.M., Zhang X.G., Zhu J.J., Gao H.M., Wang Z.M., Wang W.H. Two new triterpenoid saponins from the flowers and buds of Lonicera japonica. J. Asian Nat. Prod. Res. 2008;10:925\u2013929. doi: 10.1080/10286020802217366.", "ArticleIdList": ["10.1080/10286020802217366", "19003609"]}, {"Citation": "Dos Santos M.D., Almeida M.C., Lopes N.P., De Souza G.E.P. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol. Pharm. Bull. 2006;29:2236\u20132240. doi: 10.1248/bpb.29.2236.", "ArticleIdList": ["10.1248/bpb.29.2236", "17077520"]}, {"Citation": "Puupponen Pimi\u00e4 R., Nohynek L., Meier C., K\u00e4hk\u00f6nen M., Heinonen M., Hopia A., Oksman-Caldentey K.M. Antimicrobial properties of phenolic compounds from berries. J. Appl. Microbiol. 2001;90:494\u2013507. doi: 10.1046/j.1365-2672.2001.01271.x.", "ArticleIdList": ["10.1046/j.1365-2672.2001.01271.x", "11309059"]}, {"Citation": "Shi H., Dong L., Bai Y., Zhao J., Zhang Y., Zhang L. Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur. J. Pharmacol. 2009;623:119\u2013124. doi: 10.1016/j.ejphar.2009.09.026.", "ArticleIdList": ["10.1016/j.ejphar.2009.09.026", "19786014"]}, {"Citation": "Arion W.J., Canfield W.K., Ramos F.C., Schindler P.W., Burger H.-J., Hemmerle H., Schubert G., Below P., Herling A.W. Chlorogenic acid and hydroxynitrobenzaldehyde: New inhibitors of hepatic glucose 6-phosphatase. Arch. Biochem. Biophys. 1997;339:315\u2013322. doi: 10.1006/abbi.1996.9874.", "ArticleIdList": ["10.1006/abbi.1996.9874", "9056264"]}, {"Citation": "Herling A.W., Burger H.-J., Schubert G., Hemmerle H., Schaefer H.-L., Kramer W. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur. J. Pharmacol. 1999;386:75\u201382. doi: 10.1016/S0014-2999(99)00748-7.", "ArticleIdList": ["10.1016/S0014-2999(99)00748-7", "10611466"]}, {"Citation": "De Sotillo D.V.R., Hadley M. Chlorogenic acid modifies plasma and liver concentrations of: Cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J. Nutr. Biochem. 2002;13:717\u2013726. doi: 10.1016/S0955-2863(02)00231-0.", "ArticleIdList": ["10.1016/S0955-2863(02)00231-0", "12550056"]}, {"Citation": "Lim J.C.W., Chan T.K., Ng D.S.W., Sagineedu S.R., Stanslas J., Wong W.S.F. Andrographolide and its analogues: Versatile bioactive molecules for combating inflammation and cancer. Clin. Exp. Pharmacol. Physiol. 2012;39:300\u2013310. doi: 10.1111/j.1440-1681.2011.05633.x.", "ArticleIdList": ["10.1111/j.1440-1681.2011.05633.x", "22017767"]}, {"Citation": "Li J., Luo L., Wang X., Liao B., Li G. Inhibition of NF-\u03baB expression and allergen-induced airway inflammation in a mouse allergic asthma model by andrographolide. Cell. Mol. Immunol. 2009;6:381. doi: 10.1038/cmi.2009.49.", "ArticleIdList": ["10.1038/cmi.2009.49", "PMC4003221", "19887051"]}, {"Citation": "Guan S., Tee W., Ng D., Chan T., Peh H., Ho W., Cheng C., Mak J., Wong W. Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity. Br. J. Pharmacol. 2013;168:1707\u20131718. doi: 10.1111/bph.12054.", "ArticleIdList": ["10.1111/bph.12054", "PMC3605877", "23146110"]}, {"Citation": "Zhu T., Zhang W., Xiao M., Chen H., Jin H. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice. Int. J. Mol. Sci. 2013;14:23581\u201323596. doi: 10.3390/ijms141223581.", "ArticleIdList": ["10.3390/ijms141223581", "PMC3876064", "24300094"]}, {"Citation": "Zhang W.-J., Hufnagl P., Binder B.R., Wojta J. Anti-inflammatory activity of astragaloside IV is mediated by inhibition of NF-\u03baB activation and adhesion molecule expression. Thromb. Haemost. 2003;90:904\u2013914.", "ArticleIdList": ["14597987"]}, {"Citation": "Zheng Z., Liu D., Song C., Cheng C., Hu Z. Studies on chemical constituents and immunological function activity of hairy root of Astragalus membranaceus. Chin. J. Biotechnol. 1997;14:93\u201397.", "ArticleIdList": ["10196633"]}, {"Citation": "Gui D., Guo Y., Wang F., Liu W., Chen J., Chen Y., Huang J., Wang N. Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo. PLoS ONE. 2012;7:e39824. doi: 10.1371/journal.pone.0039824.", "ArticleIdList": ["10.1371/journal.pone.0039824", "PMC3382154", "22745830"]}, {"Citation": "Liu H., Wei W., Sun W.-Y., Li X. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells. J. Ethnopharmacol. 2009;122:502\u2013508. doi: 10.1016/j.jep.2009.01.035.", "ArticleIdList": ["10.1016/j.jep.2009.01.035", "19429320"]}, {"Citation": "Lv L., Wu S.-Y., Wang G.-F., Zhang J.-J., Pang J.-X., Liu Z.-Q., Xu W., Wu S.-G., Rao J.-J. Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Phytother. Res. 2010;24:219\u2013224. doi: 10.1002/ptr.2915.", "ArticleIdList": ["10.1002/ptr.2915", "19610026"]}, {"Citation": "Motomura K., Fujiwara Y., Kiyota N., Tsurushima K., Takeya M., Nohara T., Nagai R., Ikeda T. Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products. J. Agric. Food Chem. 2009;57:7666\u20137672. doi: 10.1021/jf9007168.", "ArticleIdList": ["10.1021/jf9007168", "19681610"]}, {"Citation": "Yu J., Zhang Y., Sun S., Shen J., Qiu J., Yin X., Yin H., Jiang S. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can. J. Physiol. Pharmacol. 2006;84:579\u2013587. doi: 10.1139/y06-015.", "ArticleIdList": ["10.1139/y06-015", "16900242"]}, {"Citation": "Chu Y., Zhang L., Wang X.-Y., Guo J.-H., Guo Z.-X., Ma X.-H. The effect of Compound Danshen Dripping Pills, a Chinese herb medicine, on the pharmacokinetics and pharmacodynamics of warfarin in rats. J. Ethnopharmacol. 2011;137:1457\u20131461. doi: 10.1016/j.jep.2011.08.035.", "ArticleIdList": ["10.1016/j.jep.2011.08.035", "21878380"]}, {"Citation": "Yang P.J., Li S.M., Lv Y.P., Huang Z.Y., Huang H. Effect of compound danshen dripping pills on vascular endothelial function in early diabetic retinopathy patients. Chin. J. Exp. Tradit. Med. Formulae. 2013;19:340\u2013343."}, {"Citation": "Lian F., Wu L., Tian J., Jin M., Zhou S., Zhao M., Wei L., Zheng Y., Wang Y., Zhang M. The effectiveness and safety of a danshen-containing Chinese herbal medicine for diabetic retinopathy: A randomized, double-blind, placebo-controlled multicenter clinical trial. J. Ethnopharmacol. 2015;164:71\u201377. doi: 10.1016/j.jep.2015.01.048.", "ArticleIdList": ["10.1016/j.jep.2015.01.048", "25666427"]}, {"Citation": "Ma G., Xu G., Xu L., Wang Z. Studies on Chemical Constituents of Dendrobium chrysotoxum Lindl. Acta Pharm. Sin. 1994;29:766."}, {"Citation": "Ng T.B., Liu J., Wong J.H., Ye X., Sze S.C.W., Tong Y., Zhang K.Y. Review of research on Dendrobium, a prized folk medicine. Appl. Microbiol. Biotechnol. 2012;93:1795\u20131803. doi: 10.1007/s00253-011-3829-7.", "ArticleIdList": ["10.1007/s00253-011-3829-7", "22322870"]}, {"Citation": "Zhao Y., Son Y.-O., Kim S.-S., Jang Y.-S., Lee J.-C. Antioxidant and anti-hyperglycemic activity of polysaccharide isolated from Dendrobium chrysotoxum Lindl. BMB Rep. 2007;40:670\u2013677. doi: 10.5483/BMBRep.2007.40.5.670.", "ArticleIdList": ["10.5483/BMBRep.2007.40.5.670", "17927899"]}, {"Citation": "Yu Z., Gong C., Lu B., Yang L., Sheng Y., Ji L., Wang Z. Dendrobium chrysotoxum Lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease. J. Diabetes Res. 2015;2015 doi: 10.1155/2015/518317.", "ArticleIdList": ["10.1155/2015/518317", "PMC4313057", "25685822"]}, {"Citation": "Takikawa M., Inoue S., Horio F., Tsuda T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J. Nutr. 2010;140:527\u2013533. doi: 10.3945/jn.109.118216.", "ArticleIdList": ["10.3945/jn.109.118216", "20089785"]}, {"Citation": "Wu X., Beecher G.R., Holden J.M., Haytowitz D.B., Gebhardt S.E., Prior R.L. Concentrations of Anthocyanins in Common Foods in the United States and Estimation of Normal Consumption. J. Agric. Food Chem. 2006;54:4069\u20134075. doi: 10.1021/jf060300l.", "ArticleIdList": ["10.1021/jf060300l", "16719536"]}, {"Citation": "Seeram N.P. Berry fruits: Compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease. J. Agric. Food Chem. 2008;56:627\u2013629. doi: 10.1021/jf071988k.", "ArticleIdList": ["10.1021/jf071988k", "18211023"]}, {"Citation": "Nakajima J.-I., Tanaka I., Seo S., Yamazaki M., Saito K. LC/PDA/ESI-MS profiling and radical scavenging activity of anthocyanins in various berries. BioMed Res. Int. 2004;2004:241\u2013247. doi: 10.1155/S1110724304404045.", "ArticleIdList": ["10.1155/S1110724304404045", "PMC1082896", "15577184"]}, {"Citation": "Colantuoni A., Bertuglia S., Magistretti M., Donato L. Effects of Vaccinium Myrtillus anthocyanosides on arterial vasomotion. Arzneim.-Forsch. 1991;41:905\u2013909.", "ArticleIdList": ["1796918"]}, {"Citation": "Lietti A., Cristoni A., Picci M. Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity. Arzneim.-Forsch. 1975;26:829\u2013832.", "ArticleIdList": ["9100"]}, {"Citation": "Matsunaga N., Chikaraishi Y., Shimazawa M., Yokota S., Hara H. Vaccinium myrtillus (Bilberry) extracts reduce angiogenesis in vitro and in vivo. Evid.-Based Complement. Altern. Med. 2010;7:47\u201356. doi: 10.1093/ecam/nem151.", "ArticleIdList": ["10.1093/ecam/nem151", "PMC2816375", "18955266"]}, {"Citation": "Kim J., Kim C.-S., Lee Y.M., Sohn E., Jo K., Kim J.S. Vaccinium myrtillus extract prevents or delays the onset of diabetes\u2014Induced blood-retinal barrier breakdown. Int. J. Food Sci. Nutr. 2015;66:236\u2013242. doi: 10.3109/09637486.2014.979319.", "ArticleIdList": ["10.3109/09637486.2014.979319", "25582181"]}, {"Citation": "Nalawade S.M., Sagare A.P., Lee C.Y., Kao C.L., Tsay H.S. Studies on tissue culture of Chinese medicinal plant resources in Taiwan and their sustainable utilization. Bot. Bull. Acad. Sin. 2003;44:79\u201398."}, {"Citation": "Prakash R.O., Rabinarayan A., Kumar M.S. Zingiber zerumbet (L.) Sm., a reservoir plant for therapeutic uses: A review. Int. J. Res. Ayurveda Pharm. 2011;2:1\u201322."}, {"Citation": "Yob N., Jofrry S.M., Affandi M., Teh L., Salleh M., Zakaria Z. Zingiber zerumbet (L.) Smith: A review of its ethnomedicinal, chemical, and pharmacological uses. Evid.-Based Complement. Altern. Med. 2011;2011:543216. doi: 10.1155/2011/543216.", "ArticleIdList": ["10.1155/2011/543216", "PMC3092606", "21584247"]}, {"Citation": "Hong T.-Y., Tzeng T.-F., Liou S.-S., Liu I.-M. The ethanol extract of Zingiber zerumbet rhizomes mitigates vascular lesions in the diabetic retina. Vasc. Pharmacol. 2016;76:18\u201327. doi: 10.1016/j.vph.2015.08.015.", "ArticleIdList": ["10.1016/j.vph.2015.08.015", "26319672"]}, {"Citation": "Raghuram T., Sharma R., Sivakumar B., Sahay B. Effect of fenugreek seeds on intravenous glucose disposition in non-insulin dependent diabetic patients. Phytother. Res. 1994;8:83\u201386. doi: 10.1002/ptr.2650080206.", "ArticleIdList": ["10.1002/ptr.2650080206"]}, {"Citation": "Marzouk M., Soliman A., Omar T. Hypoglycemic and antioxidative effects of fenugreek and termis seeds powder in streptozotocin-diabetic rats. Eur. Rev. Med. Pharmacol. Sci. 2013;17:559\u2013565.", "ArticleIdList": ["23467959"]}, {"Citation": "Chaturvedi U., Shrivastava A., Bhadauria S., Saxena J.K., Bhatia G. A mechanism-based pharmacological evaluation of efficacy of trigonella foenum graecum (fenugreek) seeds in regulation of dyslipidemia and oxidative stress in hyperlipidemic rats. J. Cardiovasc. Pharmacol. 2013;61:505\u2013512. doi: 10.1097/FJC.0b013e31828b7822.", "ArticleIdList": ["10.1097/FJC.0b013e31828b7822", "23429594"]}, {"Citation": "Sindhu G., Ratheesh M., Shyni G., Nambisan B., Helen A. Anti-inflammatory and antioxidative effects of mucilage of Trigonella foenum graecum (Fenugreek) on adjuvant induced arthritic rats. Int. Immunopharmacol. 2012;12:205\u2013211. doi: 10.1016/j.intimp.2011.11.012.", "ArticleIdList": ["10.1016/j.intimp.2011.11.012", "22155102"]}, {"Citation": "Middha S., Bhattacharjee B., Saini D., Baliga M., Nagaveni M., Usha T. Protective role of Trigonella foenum graceum extract against oxidative stress in hyperglycemic rats. Eur. Rev. Med. Pharmacol. Sci. 2011;15:427\u2013435.", "ArticleIdList": ["21608438"]}, {"Citation": "Kumar P., Kale R., McLean P., Baquer N. Antidiabetic and neuroprotective effects of Trigonella foenum-graecum seed powder in diabetic rat brain. Prague Med. Rep. 2012;113:33\u201343. doi: 10.14712/23362936.2015.35.", "ArticleIdList": ["10.14712/23362936.2015.35", "22373803"]}, {"Citation": "Hur J. Donguibogam. Namsandang; Seoul, Korea: 2007. p. 98."}, {"Citation": "Rosenfarb A. Healing Your Eyes with Chinese Medicine: Acupuncture, Acupressure Chinese Herbs. North Atlantic Books; Berkeley, CA, USA: 2007."}, {"Citation": "Lim J., Kim J., Chung S., Cho S., Oh M., Hwang W. The Antioxidative and Neuroprotective Effect of Guibi-tang (Guipitang) and Guibi-tang gamibang (Guipitang jiaweijang) on PC12 cells. J. Orient. Neuropsychiatry. 2009;20:1\u201319."}, {"Citation": "Eun J., Song J. Effects of Kwibi-tang on serum levels of hormone and the non-specific immune response after immobilization stress in mice. Korean J. Orient. Med. Physiol. Pathol. 2004;18:172\u2013178."}, {"Citation": "Kim H., Choi J., Lim S. The defensive effect of Keuibi-tang on the gastric mucous membrane of mouse injured by stress and ethanol. J. Orient. Med. 2003;24:155\u2013168."}, {"Citation": "Busta I., Xie H., Kim M.-S. The use of Gui-Pi-Tang in small animals with immune-mediated blood disorders. Korea Soc. Vet. J. 2009;26:181\u2013184."}, {"Citation": "Lee Y.M., Lee Y.-R., Kim C.-S., Jo K., Sohn E., Kim J.S., Kim J. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy. Int. J. Mol. Sci. 2015;16:29900\u201329910. doi: 10.3390/ijms161226211.", "ArticleIdList": ["10.3390/ijms161226211", "PMC4691154", "26694358"]}, {"Citation": "So H.S., Oh J., Chung Y.T., Moon Y.J., Kim D.H., Moon B.S., Lee H.S., Baek S.W., Park C., Lim Y.S., et al. The water extract of Samultang protects the lipopolysaccharide (LPS)/phorbol 12-myristate 13-acetate (PMA)-induced damage and nitric oxide production of C6 glial cells via down-regulation of NF-kappaB. Gen. Pharmacol. 2000;34:303\u2013310. doi: 10.1016/S0306-3623(00)00073-2.", "ArticleIdList": ["10.1016/S0306-3623(00)00073-2", "11368885"]}, {"Citation": "Xie M. Modern Study of the Medical Formulae in Traditional Chinese Medicine. Xue Yue Press; Beijing, China: 1997."}, {"Citation": "Lee Y.M., Kim C.-S., Jo K., Sohn E.J., Kim J.S., Kim J. Inhibitory effect of Samul-tang on retinal neovascularization in oxygen-induced retinopathy. BMC Complement. Altern. Med. 2015;15:271. doi: 10.1186/s12906-015-0800-7.", "ArticleIdList": ["10.1186/s12906-015-0800-7", "PMC4534021", "26264147"]}, {"Citation": "Yi Z., Dai X., Jiu Y. Modern Study of Medical Formulae in Traditional Chinese Medicine. Beijing Academy Press; Beijing, China: 1997."}, {"Citation": "Seo C.-S., Ha H., Jung D.-Y., Lee H.Y., Shin H.-K. Evaluation of the immune-stimulating activity of Samul-tang, a traditional Korean herbal medicine, standardized by HPLC-PDA. Korean J. Orient. Med. 2011;32:25\u201334."}, {"Citation": "Kojima S., Inaba K., Kobayashi S., Kimura M. Inhibitory effects of traditional Chinese medicine Shimotsu-to and its included crude fractions on adjuvant-induced chronic inflammation of mice. Biol. Pharm. Bull. 1996;19:47\u201352. doi: 10.1248/bpb.19.47.", "ArticleIdList": ["10.1248/bpb.19.47", "8820910"]}, {"Citation": "Yby J.Y.M., Hye Kyung H., Dae Sun H., Hyun Kyoo S. Subacute toxicity study on Samul-tang in SD rats. Korean J. Orient. Physiol. Pathol. 2008;22:137\u2013141."}, {"Citation": "State Medical License Number: Z20030017. China Food Drug Administration; Beijing, China: 2003."}, {"Citation": "Sheng S., Wang Y., Long C., Su W., Rong X. Chinese medicinal formula Fufang Xueshuantong capsule could inhibit the activity of angiotensin converting enzyme. Biotechnol. Biotechnol. Equip. 2014;28:322\u2013326. doi: 10.1080/13102818.2014.911611.", "ArticleIdList": ["10.1080/13102818.2014.911611", "PMC4433917", "26019516"]}, {"Citation": "Yuan Y.Z., Yuan F., Xu Q.Y., Yu J., Li L., Zhang J.L. Effect of Fufang Xueshuantong Capsule on a rat model of retinal vein occlusion. Chin. J. Integr. Med. 2011;17:296\u2013301. doi: 10.1007/s11655-011-0690-6.", "ArticleIdList": ["10.1007/s11655-011-0690-6", "21509674"]}, {"Citation": "Cheng Y.X. Clinical effect observation of compound xueshuantong capsule in the treatment of diabetic retinopathy. GuideChinaMed. 2013;11:215\u2013216."}, {"Citation": "Duan H., Huang J., Li W., Tang M. Protective effects of fufang xueshuantong on diabetic retinopathy in rats. Evid.-Based Complement. Altern. Med. 2013;2013 doi: 10.1155/2013/408268.", "ArticleIdList": ["10.1155/2013/408268", "PMC3800603", "24204392"]}, {"Citation": "Jian W., Yu S., Tang M., Duan H., Huang J. A Combination of the Main Constituents of Fufang Xueshuantong Capsules Shows Protective Effects against Streptozotocin-induced Retinal Lesions in Rats. J. Ethnopharmacol. 2015;182:50\u201356. doi: 10.1016/j.jep.2015.11.021.", "ArticleIdList": ["10.1016/j.jep.2015.11.021", "26692279"]}, {"Citation": "Qian W., Xiong X., Fang Z., Lu H., Wang Z. Protective effect of tetramethylpyrazine on myocardial ischemia-reperfusion injury. Evid.-Based Complement. Altern. Med. 2014;2014:1\u20139. doi: 10.1155/2014/107501.", "ArticleIdList": ["10.1155/2014/107501", "PMC4135172", "25152756"]}, {"Citation": "Tan Z. Neural protection by naturopathic compounds\u2014An example of tetramethylpyrazine from retina to brain. J. Ocul. Biol. Dis. Inform. 2009;2:57\u201364. doi: 10.1007/s12177-009-9024-8.", "ArticleIdList": ["10.1007/s12177-009-9024-8", "PMC2723671", "19672463"]}, {"Citation": "Zhang Z., Wei T., Hou J., Li G., Yu S., Xin W. Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes. Life Sci. 2003;72:2465\u20132472. doi: 10.1016/S0024-3205(03)00139-5.", "ArticleIdList": ["10.1016/S0024-3205(03)00139-5", "12650854"]}, {"Citation": "Kao T.-K., Chang C.-Y., Ou Y.-C., Chen W.-Y., Kuan Y.-H., Pan H.-C., Liao S.-L., Li G.-Z., Chen C.-J. Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. Exp. Neurol. 2013;247:188\u2013201. doi: 10.1016/j.expneurol.2013.04.010.", "ArticleIdList": ["10.1016/j.expneurol.2013.04.010", "23644042"]}, {"Citation": "Ren Z., Ma J., Zhang P., Luo A., Zhang S., Kong L., Qian C. The effect of ligustrazine on l-type calcium current, calcium transient and contractility in rabbit ventricular myocytes. J. Ethnopharmacol. 2012;144:555\u2013561. doi: 10.1016/j.jep.2012.09.037.", "ArticleIdList": ["10.1016/j.jep.2012.09.037", "23058991"]}, {"Citation": "Liao S.-L., Kao T.-K., Chen W.-Y., Lin Y.-S., Chen S.-Y., Raung S.-L., Wu C.-W., Lu H.-C., Chen C.-J. Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci. Lett. 2004;372:40\u201345. doi: 10.1016/j.neulet.2004.09.013.", "ArticleIdList": ["10.1016/j.neulet.2004.09.013", "15531085"]}, {"Citation": "Gong X., Ivanov V.N., Davidson M.M., Hei T.K. Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death. Arch. Toxicol. 2015;89:1057\u20131070. doi: 10.1007/s00204-014-1302-y.", "ArticleIdList": ["10.1007/s00204-014-1302-y", "PMC4377316", "24961358"]}, {"Citation": "Liang X., Zhou H., Ding Y., Li J., Yang C., Luo Y., Li S., Sun G., Liao X., Min W. TMP Prevents Retinal Neovascularization and Imparts Neuroprotection in an Oxygen-Induced Retinopathy ModelTMP Blocks Oxygen-Induced Retinopathy. Investig. Ophthalmol. Vis. Sci. 2012;53:2157\u20132169. doi: 10.1167/iovs.11-9315.", "ArticleIdList": ["10.1167/iovs.11-9315", "PMC4627509", "22410554"]}, {"Citation": "Ou Y., Dong X., Liu X.-Y., Cheng X.-C., Cheng Y.-N., Yu L.-G., Guo X.-L. Mechanism of tetramethylpyrazine analogue CXC195 inhibition of hydrogen peroxide-induced apoptosis in human endothelial cells. Biol. Pharm. Bull. 2010;33:432\u2013438. doi: 10.1248/bpb.33.432.", "ArticleIdList": ["10.1248/bpb.33.432", "20190405"]}, {"Citation": "Hosoya K.-I., Tomi M., Ohtsuki S., Takanaga H., Ueda M., Yanai N., Obinata M., Terasaki T. Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat. Exp. Eye Res. 2001;72:163\u2013172. doi: 10.1006/exer.2000.0941.", "ArticleIdList": ["10.1006/exer.2000.0941", "11161732"]}, {"Citation": "Zhu X., Wang K., Zhang K., Tan X., Wu Z., Sun S., Zhou F., Zhu L. Tetramethylpyrazine Protects Retinal Capillary Endothelial Cells (TR-iBRB2) against IL-1\u03b2-Induced Nitrative/Oxidative Stress. Int. J. Mol. Sci. 2015;16:21775\u201321790. doi: 10.3390/ijms160921775.", "ArticleIdList": ["10.3390/ijms160921775", "PMC4613279", "26370989"]}, {"Citation": "Kogure T., Hoshino A., Ito K., Sato H., Tatsumi T., Ohyama Y., Kawata E., Fujita K.I., Tamura J.I. Beneficial effect of complementary alternative medicine on lymphedema with rheumatoid arthritis. Mod. Rheumatol. 2005;15:445\u2013449. doi: 10.3109/s10165-005-0438-2.", "ArticleIdList": ["10.3109/s10165-005-0438-2", "17029111"]}, {"Citation": "Shin I.S., Yu Y.B., Seo C.S., Ha H.K., Lee M.Y., Huang D.S., Kim J.H., Shin H.K. Subchronic toxicity of Sipjeondaebo-tang (SDT) in Sprague-Dawley rats. Regul. Toxicol. Pharmacol. 2011;59:375\u2013384. doi: 10.1016/j.yrtph.2010.09.018.", "ArticleIdList": ["10.1016/j.yrtph.2010.09.018", "20937344"]}, {"Citation": "Tagami K., Niwa K., Lian Z., Gao J., Mori H., Tamaya T. Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. Biol. Pharm. Bull. 2004;27:156\u2013161. doi: 10.1248/bpb.27.156.", "ArticleIdList": ["10.1248/bpb.27.156", "14758024"]}, {"Citation": "Lee Y.M., Kim C.-S., Sohn E., Jo K., Lim H.R., Kim S.K., Kim J.S., Kim J. Sipjeondaebo-tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy. Tohoku J. Exp. Med. 2014;234:229\u2013236. doi: 10.1620/tjem.234.229.", "ArticleIdList": ["10.1620/tjem.234.229", "25365937"]}, {"Citation": "Altunkaya A., G\u00f6kmen V. Effect of various anti-browning agents on phenolic compounds profile of fresh lettuce (L. sativa) Food Chem. 2009;117:122\u2013126. doi: 10.1016/j.foodchem.2009.03.085.", "ArticleIdList": ["10.1016/j.foodchem.2009.03.085"]}, {"Citation": "Zhang S.-Y., Li B.-Y., Li X.-L., Cheng M., Cai Q., Yu F., Wang W.-D., Tan M., Yan G., Hu S.-L. Effects of phlorizin on diabetic retinopathy according to isobaric tags for relative and absolute quantification-based proteomics in db/db mice. Mol. Vis. 2013;19:812\u2013821.", "ArticleIdList": ["PMC3626294", "23592918"]}, {"Citation": "Bateman H.R., Liang Q., Fan D., Rodriguez V., Lessner S.M. Sparstolonin B inhibits pro-angiogenic functions and blocks cell cycle progression in endothelial cells. PLoS ONE. 2013;8:e70500. doi: 10.1371/journal.pone.0070500.", "ArticleIdList": ["10.1371/journal.pone.0070500", "PMC3734268", "23940584"]}, {"Citation": "Bucolo C., Leggio G.M., Drago F., Salomone S. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem. Pharmacol. 2012;84:88\u201392. doi: 10.1016/j.bcp.2012.03.019.", "ArticleIdList": ["10.1016/j.bcp.2012.03.019", "22484312"]}, {"Citation": "Gupta S.K., Kumar B., Nag T.C., Agrawal S.S., Agrawal R., Agrawal P., Saxena R., Srivastava S. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J. Ocul. Pharmacol. Ther. 2011;27:123\u2013130. doi: 10.1089/jop.2010.0123.", "ArticleIdList": ["10.1089/jop.2010.0123", "21314438"]}, {"Citation": "Subramoniam A. Plants with Anti-Diabetes Mellitus Properties. CRC Press; Boca Raton, FL, USA: 2016. pp. 18\u2013432."}, {"Citation": "Ibrahim A.S., El-Shishtawy M.M., Pe\u00f1a A., Liou G.I. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol. Vis. 2010;16:2033\u20132042.", "ArticleIdList": ["PMC2965567", "21042558"]}, {"Citation": "Yang L.-P., Sun H.-L., Wu L.-M., Guo X.-J., Dou H.-L., Tso M.O., Zhao L., Li S.-M. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2009;50:2319\u20132327. doi: 10.1167/iovs.08-2642.", "ArticleIdList": ["10.1167/iovs.08-2642", "19011009"]}, {"Citation": "Shi X., Liao S., Mi H., Guo C., Qi D., Li F., Zhang C., Yang Z. Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Molecules. 2012;17:12868\u201312881. doi: 10.3390/molecules171112868.", "ArticleIdList": ["10.3390/molecules171112868", "PMC6268103", "23117428"]}, {"Citation": "Wang D.-D., Zhu H.-Z., Li S.-W., Yang J.-M., Xiao Y., Kang Q.-R., Li C.-Y., Zhao Y.-S., Zeng Y., Li Y. Crude Saponins of Panax notoginseng Have Neuroprotective Effects to Inhibit Palmitate-Triggered Endoplasmic Reticulum Stress-Associated Apoptosis and Loss of Postsynaptic Proteins in Staurosporine Differentiated RGC-5 Retinal Ganglion Cells. J. Agric. Food Chem. 2016;64:1528\u20131539. doi: 10.1021/acs.jafc.5b05864.", "ArticleIdList": ["10.1021/acs.jafc.5b05864", "26832452"]}, {"Citation": "Zhao H., Shi X., Wei W., Wang N. Effect of the regimen of Gaoshan Hongjingtian on the mechanism of poly (ADP-ribose) polymerase regulation of nuclear factor kappa B in the experimental diabetic retinopathy. Chin. Med. J. 2012;126:1693\u20131699.", "ArticleIdList": ["23652053"]}, {"Citation": "Gao D., Guo Y., Li X., Li X., Li Z., Xue M., Ou Z., Liu M., Yang M., Liu S. An aqueous extract of Radix Astragali, Angelica sinensis, and Panax notoginseng is effective in preventing diabetic retinopathy. Evid.-Based Complement. Altern. Med. 2013;2013 doi: 10.1155/2013/578165.", "ArticleIdList": ["10.1155/2013/578165", "PMC3638602", "23662142"]}, {"Citation": "Kim J., Kim C.-S., Sohn E., Lee Y.M., Jo K., Kim J.S. KIOM-79 protects AGE-induced retinal pericyte apoptosis via inhibition of NF-kappaB activation in vitro and in vivo. PLoS ONE. 2012;7:e43591. doi: 10.1371/journal.pone.0043591.", "ArticleIdList": ["10.1371/journal.pone.0043591", "PMC3423361", "22916281"]}, {"Citation": "Kim O.S., Kim J., Kim C.-S., Kim N.H., Kim J.S. KIOM-79 prevents methyglyoxal-induced retinal pericyte apoptosis in vitro and in vivo. J. Ethnopharmacol. 2010;129:285\u2013292. doi: 10.1016/j.jep.2010.03.027.", "ArticleIdList": ["10.1016/j.jep.2010.03.027", "20362656"]}, {"Citation": "Liu M., Pan Q., Chen Y., Yang X., Zhao B., Jia L., Zhu Y., Zhang B., Gao X., Li X. Administration of Danhong Injection to diabetic db/db mice inhibits the development of diabetic retinopathy and nephropathy. Sci. Rep. 2015;5:11219. doi: 10.1038/srep11219.", "ArticleIdList": ["10.1038/srep11219", "PMC4462147", "26061387"]}, {"Citation": "Cheng L., Meng X.-B., Lu S., Wang T.-T., Liu Y., Sun G.-B., Sun X.-B. Evaluation of hypoglycemic efficacy of Tangningtongluo formula, a traditional Chinese Miao medicine, in two rodent animal models. J. Diabetes Res. 2014;2014 doi: 10.1155/2014/745419.", "ArticleIdList": ["10.1155/2014/745419", "PMC4238278", "25431772"]}, {"Citation": "Wang L., Wang N., Tan H.-Y., Zhang Y., Feng Y. Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy. J. Ethnopharmacol. 2015;169:295\u2013304. doi: 10.1016/j.jep.2015.04.031.", "ArticleIdList": ["10.1016/j.jep.2015.04.031", "25929449"]}, {"Citation": "Zhang F., Huang B., Zhao Y., Tang S., Xu H., Wang L., Liang R., Yang H. BNC protects H9c2 cardiomyoblasts from H2O2-induced oxidative injury through ERK1/2 signaling pathway. Evid.-Based Complement. Altern. Med. 2013;2013 doi: 10.1155/2013/802784.", "ArticleIdList": ["10.1155/2013/802784", "PMC3810482", "24223618"]}]}], "History": [{"Year": "2016", "Month": "10", "Day": "25"}, {"Year": "2016", "Month": "12", "Day": "27"}, {"Year": "2016", "Month": "12", "Day": "28"}, {"Year": "2017", "Month": "1", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["28054988", "PMC6155640", "10.3390/molecules22010076", "molecules22010076"]}}]}